IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 100
Titolo Tipologia Data di pubblicazione Autore(i) File
Fragment-Based Discovery of a Dual pan-RET/VEGFR2 Kinase Inhibitor Optimized for Single-Agent Polypharmacology 1.1 Articolo in rivista 2015 Frett, Brendan; Carlomagno, Francesca; Moccia, Marialuisa; Brescia, Annalisa; Federico, Giorgia; De Falco, Valentina; Admire, Brittany; Chen, Zhongzhu; Qi, Wenqing; Santoro, Massimo; Li, Hong yu
Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase 1.1 Articolo in rivista 2015 Moccia, Marialuisa; Liu, Qingsong; Guida, Teresa; Federico, Giorgia; Brescia, Annalisa; Zhao, Zheng; Choi, Hwan Geun; Deng, Xianming; Tan, Li; Wang, Jinhua; Billaud, Marc; Gray, Nathanael S; Federico, Giorgia; Santoro, Massimo
Functional characterization of a novel FGFR1OP-RET rearrangement in hematopoietic malignancies. 1.1 Articolo in rivista 2014 Bossi, D; Carlomagno, Francesca; Pallavicini, I; Pruneri, G; Trubia, M; Raviele, Pr; Marinelli, A; Anaganti, S; Cox, Mc; Viale, G; Santoro, Massimo; Di Fiore, Pp; Minucci, S.
Identification of two novel RET kinase inhibitors through MCR-based drug discovery: design, synthesis and evaluation 1.1 Articolo in rivista 2014 Frett, B; Moccia, M; Carlomagno, Francesca; Santoro, Massimo; Li, Hy
Growth factor transduction pathways: paradigm of anti-neoplastic targeted therapy 1.1 Articolo in rivista 2014 Carlomagno, Francesca; Chiariello, Mario
NCOA4 transcriptional coactivator inhibits activation of DNA replication origins. 1.1 Articolo in rivista 2014 Bellelli, Roberto; Castellone, Md; Guida, T; Limongello, R; Dathan, Na; Merolla, Francesco; Cirafici, Am; Affuso, A; Masai, H; Costanzo, Vincenzo; Grieco, Domenico; Fusco, Alfredo; Santoro, Massimo; Carlomagno, Francesca
Oncogenic rearrangements driving ionizing radiation-associated human cancer 1.1 Articolo in rivista 2013 Santoro, Massimo; Carlomagno, Francesca
Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer. 1.1 Articolo in rivista 2013 De Falco, V; Buonocore, Preziosa; Muthu, M; Torregrossa, L; Basolo, F; Billaud, M; Gozgit, Jm; Carlomagno, Francesca; Santoro, Massimo
Structure prediction and validation of the ERK8 kinase domain. 1.1 Articolo in rivista 2013 Strambi, A; Mori, M; Rossi, M; Colecchia, D; Manetti, F; Carlomagno, Francesca; Botta, M; Chiariello, M.
Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL receptor tyrosine kinase degradation. 1.1 Articolo in rivista 2013 Krishnamoorthy, GNAMA PRAKASAM; Guida, Teresa; Alfano, L; Avilla, Elvira; Santoro, Massimo; Carlomagno, Francesca; Melillo, ROSA MARINA
Central role of RET in thyroid cancer 1.1 Articolo in rivista 2013 Santoro, Massimo; Carlomagno, Francesca
Attacking cancer with molecularly targeted agents 1.1 Articolo in rivista 2013 Santoro, Massimo; Carlomagno, Francesca
NCOA4 inhibits initiation of DNA replication to maintain genome stability 4.2 Abstract in Atti di convegno 2012 Bellelli, Roberto; Castellone, MARIA DOMENICA; Guida, Teresa; Annamaria, Cirafici; Francesco, Merolla; Livia, Provitera; Roberto, Limongello; Nina, Dathan; Grieco, Domenico; Costanzo, Vincenzo; Fusco, Alfredo; Santoro, Massimo; Carlomagno, Francesca
Therapeutic strategies to target the receptor tyrosine kinase AXL in thyroid cancer 4.2 Abstract in Atti di convegno 2012 Gnanaprakasam, Krisnamoorthy; Guida, Teresa; Visciano, Carla; Liotti, Federica; Carlomagno, Francesca; Melillo, ROSA MARINA
The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells. 1.1 Articolo in rivista 2011 Vitagliano, Donata; De Falco, V.; Tamburrino, Anna; Coluzzi, S.; Troncone, Giancarlo; Chiappetta, G.; Ciardiello, F; Tortora, G.; Fagin, J.; Ryan, A. J.; Carlomagno, Francesca; Santoro, Massimo
Thyroid cancer in 2010: A roadmap for targeted therapies 1.1 Articolo in rivista 2011 Carlomagno, Francesca; Santoro, Massimo
RET Is a Heat Shock Protein 90 (HSP90) Client Protein and Is Knocked Down upon HSP90 Pharmacological Block. 1.1 Articolo in rivista 2010 Alfano, L.; Guida, T.; Provitera, L.; Vecchio, Giancarlo; Billaud, M.; Santoro, Massimo; Carlomagno, Francesca
I geni oncosoppressori in "Patologia Generale" IV Ed, Pontieri-Russo-Frati 3.1 Monografia o trattato scientifico 2009 Santoro, Massimo; Carlomagno, F; Vecchio, Giancarlo
Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474 1.1 Articolo in rivista 2009 Carlomagno, Francesca; Guida, T.; Anaganti, S.; Provitera, L.; Kjaer, S.; Mcdonald, N. Q.; Ryan, A. J.; Santoro, Massimo
Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma. 1.1 Articolo in rivista 2009 Nappi, T.; Salerno, P.; Zitzelsberger, H.; Carlomagno, Francesca; Salvatore, G.; Santoro, Massimo
Mostrati risultati da 21 a 40 di 100
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile